Gulf Capital Successfully Exits ART Fertility Clinics’ Middle East Operations Selling Its Stake To IVI-RMA Global, World Leader In Fertility And Assisted Reproduction
Since its acquisition in 2020, ART Fertility Clinics has undergone a period of significant growth and transformation. Under Gulf Capital's ownership, ART expanded from a UAE-focused business into a regional fertility platform with 15 clinics, including 3 in the UAE, 1 in Saudi, and 11 in India. The scope of the transaction includes the clinics located in UAE and Saudi Arabia, while the India operation will remain under the ownership of Gulf Capital. In the Middle East alone, ART Fertility Clinics has delivered substantial revenue and EBITDA growth since 2020, with profitability quadrupling over the last five years. This strong financial performance has been underpinned by ART’s reputation for clinical excellence, rapid regional expansion and some of the highest success rates in IVF treatments across the region.
Under Gulf Capital ownership, ART Fertility achieved a transformation that scaled the platform from a single-country operator to the regional leader in reproductive medicine. During this ownership period, ART Fertility invested heavily in science and research with 220 medical publications to date and launched a pioneering genetic testing lab in Abu Dhabi, leading to some of the highest IVF fertility success rates globally. ART Fertility’s expansion and financial performance underline Gulf Capital’s deep focus on operational improvements and growth. Following a competitive auction, the successful sale of the company to a global strategic buyer highlights Gulf Capital’s ability to source, grow and exit healthcare platforms at very attractive multiples.
As one of the most vital and fast-evolving industries in the GCC, healthcare continues to offer both meaningful impact and long-term growth opportunities. ART Fertility stands as a testament to that potential. Over the past few years, Gulf Capital has helped build a business that combines scale, profitability, and clinical leadership – three elements that are often difficult to align.
